In our SIRS/sepsis cohort, plasma apoA-IV levels were comparable in patients with and without cirrhosis, suggesting that cirrhosis does not have a major effect on the synthesis and/or clearance of this apolipoprotein, which also does not appear to contribute to the reduced lipid levels in cirrhosis. The gene discussed is APOA4; the disease is systemic inflammatory response syndrome.